Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-11-06FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental NDA for XTANDI (enzalutamide) submitted by Astellas Pharma US, Inc., to update the labeling and/or expand an ind…
-
CLINICAL_TRIALS research · 2015-11-05Clinical Trial Update: Biomarkers of Bone Resorption in Metastatic Prostate Cancer
The University of Aberdeen completed a clinical trial evaluating biomarkers of bone resorption in metastatic prostate cancer.
-
CLINICAL_TRIALS research · 2015-11-05Clinical Trial Update: Salvage Radiotherapy After Radical Prostatectomy
A clinical trial update on salvage radiotherapy after radical prostatectomy for prostate cancer, sponsored by the University of Aarhus; curr…
-
CLINICAL_TRIALS trial_result · 2015-11-04Clinical Trial Update: A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel [Phase 2]
A Phase 2 trial evaluating the safety and efficacy of abiraterone in men with prostate cancer who have previously received docetaxel has com…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: Vitamin D in Treating Patients With Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating vitamin D for treating prostate cancer has completed and results are posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-10-30Clinical Trial Update: Positron Emission Tomography in Prostate Cancer [NA]
Clinical trial update on positron emission tomography imaging in prostate cancer (NCT00121212) with status completed.
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Cinacalcet Hydrochloride in Treating Men With Recurrent Prostate Cancer [Phase 2]
A Phase 2 clinical trial evaluating cinacalcet hydrochloride in men with recurrent prostate cancer has completed, with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2015-10-29Clinical Trial Update: Measurements Of Zinc Concentration On Specimens Taken During Trans-Perineal Prostate Biopsy
This clinical trial update summarizes zinc concentration measurements in specimens taken during trans-perineal prostate biopsy for prostate …
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: Induction and Maintenance of Castration After Subcutaneous Injections of Triptorelin Pamoate in Patients With Prostate Cancer [Phase 3]
Phase 3 clinical trial evaluating induction and maintenance of castration with subcutaneous triptorelin pamoate in prostate cancer patients …
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism [Phase 4]
Phase 4 MRI substudy examining metabolic changes related to iatrogenic hypogonadism in patients with prostate cancer and metabolic syndrome;…
-
FDA approval · 2015-10-27FDA Approved: FIRMAGON — Supplemental Application (Ferring Pharmaceuticals Inc.)
The FDA approved a supplemental application for Firmagon (degarelix) submitted by Ferring Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2015-10-27Clinical Trial Update: Molecular Effects of a Multi-carotenoids (MCS) New Agent on Prostate Cancer Chemoprevention
A clinical trial update examining the molecular effects of a new multi-carotenoids agent (MCS) for chemoprevention of prostate cancer; the s…
-
CLINICAL_TRIALS trial_result · 2015-10-26Clinical Trial Update: Efficacy Study of ABR-215050 to Treat Prostate Cancer [Phase 2]
The document reports the completion of a Phase 2 efficacy study evaluating ABR-215050 for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2015-10-23Clinical Trial Update: BMTP-11 in Patients With Castrate-Resistant Prostate Cancer With Bone Mets [Phase 1]
Phase 1 trial of BMTP-11 for castration-resistant prostate cancer with bone metastases has completed; the update does not provide specific r…
-
CLINICAL_TRIALS trial_result · 2015-10-21Clinical Trial Update: Exercise for Physical Health in Men With Prostate Cancer [NA]
This entry provides an update on a clinical trial evaluating an exercise program to improve physical health in men with prostate cancer.
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: A Clinical Trial to Determine the Most Suitable Dose of OPB-111001 in Patients With Advanced Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating OPB-111001 in multiple advanced cancers has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-10-20Clinical Trial Update: Prostate Biomarker Study
The document reports the completion of a prostate cancer biomarker clinical trial sponsored by Memorial Sloan Kettering Cancer Center.
-
CLINICAL_TRIALS trial_result · 2015-10-15Clinical Trial Update: CMT-07-08: The PROstate Bed Evaluation Study
This clinical trial update reports that the PROstate Bed Evaluation Study (CMT-07-08), sponsored by Varian (a Siemens Healthineers company),…
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Dissemination of Prostate Cancer Screening to PCP's in African American Communities [Phase 4]
Phase 4 trial evaluating the dissemination of prostate cancer screening to primary care physicians in African American communities has been …
-
CLINICAL_TRIALS trial_result · 2015-10-14Clinical Trial Update: Role of PET/CT With Fluorine-18 Tracers of Bone Metastases in Prostate Cancer
This completed clinical trial assesses the role of Fluorine-18 PET/CT imaging for detecting bone metastases in prostate cancer.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Hyperpolarized Pyruvate Injection in Subjects With Prostate Cancer [Phase 1]
Phase 1 clinical trial evaluating hyperpolarized pyruvate injections in patients with prostate cancer has completed. The update summarizes s…
-
CLINICAL_TRIALS withdrawal · 2015-10-05Clinical Trial Update: Ipilimumab and GMCSF Immunotherapy for Prostate Cancer [Phase 2]
Phase 2 trial of ipilimumab with GM-CSF immunotherapy for prostate cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-02Clinical Trial Update: Study of CGC-11047 in Patients With Metastatic Hormone Refractory Prostate Cancer [Phase 2]
A Phase 2 study of CGC-11047 in metastatic hormone-refractory prostate cancer was terminated.
-
FDA approval · 2015-10-01FDA Approved: XTANDI — Supplemental Application (Astellas Pharma US, Inc.)
FDA approved a supplemental application for XTANDI (enzalutamide) submitted by Astellas Pharma US, Inc., reflecting an updated indication/la…
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: S0437 Long-Term Follow-Up of Patients Who Were Diagnosed With Prostate Cancer on PCPT
This is a long-term follow-up update from the S0437 Prostate Cancer Prevention Trial, examining outcomes of men who were diagnosed with pros…